Reddy Rheumatology of Northwest in PC

Reddy Rheumatology of Northwest in PC was paid $3.37M by Medicaid between Jan 2018 and Nov 2024, across 24 billing codes. Its largest line is J0129, Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) — 61% of everything it billed.

Compared with peers

Next to other Rheumatology Physician providers in Indiana

Rank by total paid#2 of 13

Median peer was paid$124K

This provider vs. median27×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider

By year, as a table

Year	Claims	Paid
2018	864	$0.00
2019	1,190	$15K
2020	1,557	$374K
2021	2,415	$615K
2022	2,806	$936K
2023	3,442	$1.19M
2024incomplete	2,090	$238K

Box 24 · Service lines

What it billed for

Code	Service	Share	Claims	Bene. records	Paid
J0129	Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered)	61%	1,528	1,212	$2.06M
J0717	Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered)	26%	760	586	$862K
99213	Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity	7.2%	7,095	6,426	$244K
96413	Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance	1.8%	1,390	1,021	$60K
99204	Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity	1.7%	557	523	$56K
99214	Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity	1.1%	550	490	$38K
96401		1.1%	498	393	$36K
82306	Vitamin D; 25 hydroxy, includes fraction(s), if performed	<1%	342	324	$5K
86235		<1%	46	38	$3K
99215	Doctor's office visit, returning patient (complex)Prolong outpt/office vis	<1%	18	17	$2K
96365	Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour	<1%	736	557	$2K
99442		<1%	82	56	$2K

12 more codes

83516		<1%	106	$1K
86200		<1%	138	$987.50
96372	Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular	<1%	85	$952.82
99203	Doctor's office visit, new patient (routine)	<1%	15	$424.06
86225		<1%	46	$362.70
86431		<1%	106	$340.12
86226		<1%	46	$319.67
96127		<1%	13	$23.66
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established)	<1%	15	$3.12
80305		0%	50	$0.00
G0444	Annual depression screening, 5 to 15 minutes	0%	15	$0.00
G0480	Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed	0%	127	$0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialLONGACRE, JUDITH (ADMINISTRATIVE ASSISTANT)